126 related articles for article (PubMed ID: 3477801)
1. Identification and biochemical characterization of p70TRK, product of the human TRK oncogene.
Mitra G; Martin-Zanca D; Barbacid M
Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6707-11. PubMed ID: 3477801
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.
Mitra G
Oncogene; 1991 Dec; 6(12):2237-41. PubMed ID: 1837350
[TBL] [Abstract][Full Text] [Related]
3. The trk family of oncogenes and neurotrophin receptors.
Lamballe F; Klein R; Barbacid M
Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of activation of the human trk oncogene.
Coulier F; Martin-Zanca D; Ernst M; Barbacid M
Mol Cell Biol; 1989 Jan; 9(1):15-23. PubMed ID: 2538716
[TBL] [Abstract][Full Text] [Related]
5. Frequent generation of oncogenes by in vitro recombination of TRK protooncogene sequences.
Oskam R; Coulier F; Ernst M; Martin-Zanca D; Barbacid M
Proc Natl Acad Sci U S A; 1988 May; 85(9):2964-8. PubMed ID: 3362859
[TBL] [Abstract][Full Text] [Related]
6. Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain.
Coulier F; Kumar R; Ernst M; Klein R; Martin-Zanca D; Barbacid M
Mol Cell Biol; 1990 Aug; 10(8):4202-10. PubMed ID: 1695324
[TBL] [Abstract][Full Text] [Related]
7. Molecular and biochemical characterization of the human trk proto-oncogene.
Martin-Zanca D; Oskam R; Mitra G; Copeland T; Barbacid M
Mol Cell Biol; 1989 Jan; 9(1):24-33. PubMed ID: 2927393
[TBL] [Abstract][Full Text] [Related]
8. The trk oncogene abrogates growth factor requirements and transforms hematopoietic cells.
Katzav S; Martin-Zanca D; Barbacid M; Hedge AM; Isfort R; Ihle JN
Oncogene; 1989 Sep; 4(9):1129-35. PubMed ID: 2674855
[TBL] [Abstract][Full Text] [Related]
9. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences.
Martin-Zanca D; Hughes SH; Barbacid M
Nature; 1986 Feb 27-Mar 5; 319(6056):743-8. PubMed ID: 2869410
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic activation of the human trk proto-oncogene by recombination with the ribosomal large subunit protein L7a.
Ziemiecki A; Müller RG; Fu XC; Hynes NE; Kozma S
EMBO J; 1990 Jan; 9(1):191-6. PubMed ID: 2403926
[TBL] [Abstract][Full Text] [Related]
11. C127 cells resistant to transformation by tyrosine protein kinase oncogenes.
Cuadrado A; Talbot N; Barbacid M
Cell Growth Differ; 1990 Jan; 1(1):9-15. PubMed ID: 2150330
[TBL] [Abstract][Full Text] [Related]
12. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific expression of the human tropomyosin gene involved in the generation of the trk oncogene.
Reinach FC; MacLeod AR
Nature; 1986 Aug 14-20; 322(6080):648-50. PubMed ID: 3018581
[TBL] [Abstract][Full Text] [Related]
14. K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors.
Tapley P; Lamballe F; Barbacid M
Oncogene; 1992 Feb; 7(2):371-81. PubMed ID: 1312698
[TBL] [Abstract][Full Text] [Related]
15. Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences.
Kozma SC; Redmond SM; Fu XC; Saurer SM; Groner B; Hynes NE
EMBO J; 1988 Jan; 7(1):147-54. PubMed ID: 2966065
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
Albor A; Thraves PJ; Dritschilo A; Notario V
Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases.
Gonzatti-Haces M; Seth A; Park M; Copeland T; Oroszlan S; Vande Woude GF
Proc Natl Acad Sci U S A; 1988 Jan; 85(1):21-5. PubMed ID: 3277171
[TBL] [Abstract][Full Text] [Related]
18. Somatic rearrangement of the tropomyosin-receptor-kinase (trk) oncogene is rare in gastrointestinal cancer.
Fey MF; Thein SL
Br J Cancer; 1988 Apr; 57(4):403-4. PubMed ID: 3390374
[No Abstract] [Full Text] [Related]
19. Isolation of temperature-sensitive tyrosine kinase mutants of v-abl oncogene by screening with antibodies for phosphotyrosine.
Kipreos ET; Lee GJ; Wang JY
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1345-9. PubMed ID: 2434953
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of human trk proto-oncogene product monoclonal antibodies.
Eager KB
Oncogene; 1991 May; 6(5):819-24. PubMed ID: 2052359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
